Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 8.513\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) COC(=O)CCCC1=CC2=CC(=O)C(C)(OC(=O)c3cccs3)C(=O)C2=CN1CC1CC1
b.) CCO[C@H]1OC(C(=O)O)=C[C@@H](c2coc3ccccc3c2=O)[C@@H]1CCCO
c.) NC(=O)CS(=O)(=O)c1nc2ccccc2n1CC(=O)N1CCCCC1
Answer: c. NC(=O)CS(=O)(=O)c1nc2ccccc2n1CC(=O)N1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
NC(=O)CS(=O)(=O)c1nc2ccccc2n1CC(=O)N1CCCCC1
NC(=O)CS(=O)(=O)c1nc2ccccc2n1CC(=O)N1CCCCC1
2-[1-(2-oxo-2-piperidin-1-ylethyl)benzimidazol-2-yl]sulfonylacetamide